Comparative-Effectiveness Research

Comparative Effectiveness Research


 Comparative Effectiveness Research (CER) compares different interventions and strategies to prevent, diagnose, treat and monitor health conditions.  The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances.  To provide this information, comparative effectiveness research must assess a comprehensive array of health-related outcomes for diverse patient populations.

Dr. Li-Wu Chen serves as the faculty advisor for CER at UNMC.  Dr. Chen's main research interest is in public health services and systems research (PHSSR). He has directed and conducted several PHSSR projects that were funded by the Robert Wood Johnson Foundation (RWJF). As the co-principal investigator of the RWJF-funded Nebraska Public Health Practice-Based Research Network, Dr. Chen has actively engaged various stakeholders from Nebraska’s public health practice and policy communities in the development, implementation, dissemination, and translation of PHSSR.

Read more about Dr. Chen's Research...

Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide  A resource developed by the Agency for Healthcare Research and Quality (AHRQ).  Link to user guide

CER Champion

Li-Wu Chen, PhD
Chair Department of Health Services Research
College of Public Health, UNMC

PCORI Roundtable

Building a National Data Infrastructure to Advance Patient-Centered Comparative Effectiveness Research

When: Tuesday, April 23, 2013, 9:00-11:00 a.m. ET (Light breakfast available at 8:00 a.m.)
Where: The National Press Club in Washington, D.C.
RSVP: Friday, April 19, 2013, by 5:00 p.m. ET (If registration reaches the venue's capacity, registration will close before this time.)

On Tuesday, April 23, PCORI will host a roundtable discussion on how to create a national data infrastructure to support high-quality patient-centered CER.  The roundtable will bring together representatives from government, industry, payers, health systems, and the research and patient communities to discuss the challenges and opportunities in creating such a research infrastructure and where PCORI's investments can provide unique value. Audience members will be able to pose questions to roundtable participants toward the end of the event.

A webcast will be available for those who can't attend in person. Individuals who wish to attend in person should register for the event through the PCORI website. The event agenda will be updated as roundtable participants are confirmed.